{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-015653","form_type":"8-K","ticker":"ASBP","cik":"0001847345","company_name":"Aspire Biopharma Holdings, Inc.","filed_at":"2025-06-18T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.123674+00:00","generated_at":"2026-05-19T03:25:00.308207+00:00","sec_items":["8.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Aspire Biopharma moves principal executive office to Estero, Florida","bullets":["Board changed principal executive office to 23150 Fashion Drive, Suite 232, Estero, FL 33928 effective June 17, 2025.","Former address was 194 Candelaro Drive, #233, Humacao, Puerto Rico 00791.","New office is the company's principal place of business and headquarters."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-015653","json":"https://secwatch.observer/filing/0001641172-25-015653.json","markdown":"https://secwatch.observer/filing/0001641172-25-015653.md","text":"https://secwatch.observer/filing/0001641172-25-015653.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1847345/000164117225015653/0001641172-25-015653-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1847345/000164117225015653/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T03:25:00.308207+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}